Abstract: Disclosed are a method and apparatus for generating identification information for a virtual space that are capable of supporting users in searching for a virtual space. The method of generating identification information for a virtual space includes: setting a plurality of crawling points for each crawling area in a three-dimensional virtual grid shape for a virtual space; collecting at least one of a street view image and an aerial view image in a preset direction at the crawling point; and generating a spatial descriptor for each of the crawling points from the collected image.

Abstract: The present invention relates to an electrolyte composition including a lithium salt; a non-aqueous organic solvent; a compound represented by a specific formula; and a perfluoropolyether oligomer, a gel polymer electrolyte including a polymer network which is formed by a polymerization reaction of the electrolyte composition, and a lithium secondary battery including the same.

Abstract: Provided are a display device and method of changing a display setting. According to an aspect of an exemplary embodiment, the method of changing a display setting in a display device includes operations of: storing a plurality of display settings corresponding to a plurality of game categories; determining a display setting to be used for displaying video data of a currently running game among the plurality of display settings; and changing an actual display setting of the display device according to a determined display setting.

Abstract: The present invention relates to a pharmaceutical composition for the prevention, alleviation or treatment of muscular dystrophy, containing a ROR? activator JC1-40. A composition according to the present invention increases mitochondrial membrane potential, increases the number of mitochondria, and increases the expression or activity of mitochondria-related genes or proteins to thus increase biosynthesis of mitochondria, and is thus expected to be effective in the prevention, alleviation and treatment of muscular dystrophy.

Abstract: One embodiment of the present disclosure provides an extracellular matrix-based hybrid ink for 3D printing, the hybrid ink including an extracellular matrix having an amine group and a modified hyaluronic acid introduced with an ethylenically unsaturated bond functional group, in which the extracellular matrix and the modified hyaluronic acid are in a crosslinked state by a chemical bond formed between at least some of amine groups present in the extracellular matrix and the ethylenically unsaturated bond functional group present in the modified hyaluronic acid. According to an embodiment of the present disclosure, the hybrid ink has mechanical properties suitable for 3D printing through chemical crosslinking between the extracellular matrix and modified hyaluronic acid as constituents, and can control the drug release rate by adjusting the chemical crosslinking density.

Abstract: A learning data set enhancing method comprises the steps of: determining a first initial learning data set comprising a first learning-purpose natural language query, database information regarding the database, and a first learning-purpose SQL query corresponding to the first learning-purpose natural language query; generating first novel database information regarding a first novel database having a different schema from the database by applying a first schema modification operation to the database; generating a first novel learning-purpose SQL query regarding the first novel database by applying a first SQL query synchronization operation corresponding to the first schema modification operation to the first learning-purpose SQL query; and determining a first novel learning data set comprising the first learning-purpose natural language query, the first novel database information, and the first novel learning-purpose SQL query.

Abstract: The present invention relates to a novel benzopyran derivative useful for preparing a drug for treating cancer, and more specifically, to a novel benzopyran derivative which is a micromolecule having a macrophage inhibitory effect and is useful for preparing a drug for cancer treatment. The drug particularly inhibits the differentiation of immune macrophages to stimulate the immune system, and thus is useful for treating immune-related cancers.

Abstract: Provided are a display device and method of changing a display setting. According to an aspect of an exemplary embodiment, the method of changing a display setting in a display device includes operations of: storing a plurality of display settings corresponding to a plurality of game categories; determining a display setting to be used for displaying video data of a currently running game among the plurality of display settings; and changing an actual display setting of the display device according to a determined display setting.

Abstract: The present invention relates to a derivative compound in which a biphenyl group is introduced into an aminoalkanoic acid, a stereoisomer thereof, or a pharmaceutically acceptable salt thereof. The compound of the present invention exhibits excellent antifungal and fungicidal effects. Furthermore, the compound of the present invention exhibits a synergistic effect when used in combination with a conventional antifungal agent. Furthermore, the compound of the present invention provides broad-spectrum antifungal activity against a wide range of fungal pathogens. Therefore, the compound of the present invention may be widely used in fields requiring treatment with antifungal or fungicidal agents against human pathogenic fungi and animal pathogenic fungi, and phytopathogenic fungi.

Abstract: Provided is a non-aqueous electrolyte comprising a lithium salt; an organic solvent; and a compound represented by Formula 1 as an additive: wherein in Formula 1, R1 may be an alkyl group having 1 to 5 carbon atoms and optionally being substituted with fluorine, an aryl group having 6 to 8 carbon atoms and optionally being substituted with fluorine, or a nitrile group; and R2 to R4 are each independently an alkyl group having 1 to 5 carbon atoms.

Abstract: The present invention relates to a derivative compound in which a biphenyl group is introduced into an aminoalkanoic acid, a stereoisomer thereof, or a pharmaceutically acceptable salt thereof. The compound of the present invention exhibits excellent antifungal and fungicidal effects. Furthermore, the compound of the present invention exhibits a synergistic effect when used in combination with a conventional antifungal agent. Furthermore, the compound of the present invention provides broad-spectrum antifungal activity against a wide range of fungal pathogens. Therefore, the compound of the present invention may be widely used in fields requiring treatment with antifungal or fungicidal agents against human pathogenic fungi and animal pathogenic fungi, and phytopathogenic fungi.

Abstract: A light path control member according to an embodiment comprises: a first substrate by which a first direction and a second direction are defined; a first electrode disposed on the first substrate; a second substrate disposed on the first substrate; a second electrode disposed under the second substrate; and a light conversion unit disposed between the first electrode and the second electrode, wherein the light conversion unit comprises: a plurality of partitions; a plurality of accommodation units; and a base, wherein the accommodation units extend in the second direction, the first electrode includes a plurality of first pattern electrodes extending in the second direction and spaced apart from each other, and the first pattern electrodes overlap the accommodation units.

Abstract: An optical probe includes a light source configured to generate an optical signal, a plurality of waveguides configured to guide the optical signal to a target, a plurality of electrodes configured to record an electrical signal generated by the target, and a modulator configured to transmit the optical signal of the light source to at least one target waveguide from among the plurality of waveguides.

Abstract: The present invention relates to a derivative compound in which a biphenyl group is introduced into an aminoalkanoic acid, a stereoisomer thereof, or a pharmaceutically acceptable salt thereof. The compound of the present invention exhibits excellent antifungal and fungicidal effects. Furthermore, the compound of the present invention exhibits a synergistic effect when used in combination with a conventional antifungal agent. Furthermore, the compound of the present invention provides broad-spectrum antifungal activity against a wide range of fungal pathogens. Therefore, the compound of the present invention may be widely used in fields requiring treatment with antifungal or fungicidal agents against human pathogenic fungi and animal pathogenic fungi, and phytopathogenic fungi.

Abstract: A lithium secondary battery includes a positive electrode; a negative electrode; a separator interposed between the positive electrode and the negative electrode; and a non-aqueous electrolyte. The positive electrode includes a positive electrode active material, the positive electrode material includes a lithium transition metal oxide represented by a specific chemical formula, the non-aqueous electrolyte includes a lithium ion, an organic solvent, and an additive, the additive includes a first first additive and a second additive, the first additive includes a phosphate-based additive having a silyl group, and the second additive includes a compound represented by a specific chemical formula.

Abstract: A non-aqueous electrolyte includes an organic solvent, a compound represented by Formula 1 as a first additive, and a compound represented by Formula 2 or Formula 3 as a second additive: in the formulas, R and R1 to R6 are as defined in the specification.

Abstract: A lithium secondary battery includes a positive electrode; a negative electrode; a separator interposed between the positive electrode and the negative electrode; and a non-aqueous electrolyte. The positive electrode includes a positive electrode active material, the positive electrode material includes a perlithium manganese-rich oxide containing about 50 mol % or more of Mn based on all metal elements excluding lithium, and having a molar ratio of lithium to transition metal exceeding about 1, the non-aqueous electrolyte includes a lithium ion, an organic solvent, and an additive, the organic solvent includes a first organic solvent and a second organic solvent, the first organic solvent includes ethylene carbonate, the second organic solvent includes diethyl carbonate and ethyl methyl carbonate, and the additive includes cyclic sulfoxide represented by a specific chemical formula.

Abstract: A lithium secondary battery includes a positive electrode; a negative electrode; a separator interposed between the positive electrode and the negative electrode; and a non-aqueous electrolyte. The positive electrode includes a positive electrode active material, the positive electrode material includes a perlithium manganese-rich oxide containing about 50 mol % or more of Mn based on all metal elements excluding lithium, and having a molar ratio of lithium to transition metal exceeding about 1, the non-aqueous electrolyte includes a lithium ion and an organic solvent, the organic solvent includes a first organic solvent and a second organic solvent, the first organic solvent includes ethylene carbonate, and the second organic solvent includes diethyl carbonate and propyl propionate.

Abstract: A lithium secondary battery includes: a negative electrode including a silicon-based negative electrode active material; a positive electrode; a separator; and a non-aqueous electrolyte. The non-aqueous electrolyte contains: a lithium salt; an organic solvent; a compound of Formula 1 as a first additive; and a compound of Formula 2 as a second additive. Here, R is an alkylene group with 1 to 5 carbon atoms, which is substituted with fluorine, and R1 to R3 are each independently any one selected from the group consisting of H, an alkyl group with 1 to 5 carbon atoms, and a nitrile group. Here, R4 to R7 are each independently any one selected from the group consisting of an alkyl group with 1 to 10 carbon atoms, which is substituted with fluorine, and an alkenyl group with 2 to 10 carbon atoms, which is substituted with fluorine.

Abstract: A lithium secondary battery including a negative electrode comprising a carbon material as a negative electrode active material, a positive electrode comprising a positive electrode active material of Formula 2, a separator interposed between the negative electrode and the positive electrode, and a non-aqueous electrolyte comprising a lithium salt; a non-aqueous organic solvent; a first additive represented by Formula 1; and a second additive which is at least one selected from the group consisting of vinylene carbonate and vinylethylene carbonate is described, in Formulas 1 and 2, all the variables are described herein.